US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco DB G10 Currency Harvest Fund

25.41

0.0000

Volume:- -

Turnover:- -

Market Cap:7.62M

PE:21.29

High:25.41

Open:25.41

Low:25.41

Close:25.41

52wk High:28.40

52wk Low:24.25

Shares:300.04K

Float Shares:300.04K

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.19

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

Cantor Fitzgerald Reaffirms Their Buy Rating on DBV Technologies SA – American (DBVT)

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday

Benzinga_recent_news

DBV Technologies Is Maintained at Buy by Guggenheim

U.S. Stocks to Watch: Tesla, Netflix, Lennar, DBV Technologies, Micron, and More

Stocks to Watch: DBV Technologies, Children's Place, Worthington

DBV Technologies Peanut Allergy Patch Meets Primary Endpoint in Trial

Cantor Fitzgerald Initiates DBV Technologies With Overweight Rating, $42 Price Target

MT Newswires Live

DBV Technologies Is Maintained at Buy by HC Wainwright & Co.

DBV Technologies Initiated at Overweight by Cantor Fitzgerald

DBV Technologies Initiated at Buy by Guggenheim

Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments

DBV Technologies announces last patient visit completed in VITESSE trial

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

Kepler Capital Reaffirms Their Buy Rating on DBV Technologies (0QAJ)

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors

DBV Technologies to Sell $30 Million of ADSs Under ATM Program

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DBV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DBV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DBV\",,,,,undefined,":{"symbol":"DBV","market":"US","secType":"STK","nameCN":"Invesco DB G10 Currency Harvest Fund","latestPrice":25.41,"timestamp":1729886400000,"preClose":25.41,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":300040,"shares":300040,"eps":1.1933,"marketStatus":"Trading","change":0,"latestTime":"02-12 11:48:36 EST","open":25.41,"high":25.41,"low":25.41,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.1933,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":25.41,"sharesOutstanding":300040,"nav":25.701,"aum":7711306.3,"bidAskSpread":0.018526,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DBV\",,,,,undefined,":{"symbol":"DBV","floatShares":300040,"roa":"--","roe":"--","lyrEps":0,"shares":300040,"dividePrice":0,"high":25.41,"amplitude":0,"preClose":25.41,"low":25.41,"week52Low":24.25,"pbRate":"--","week52High":28.4,"institutionHeld":0,"latestPrice":25.41,"eps":1.1933,"divideRate":0,"volume":0,"delay":0,"ttmEps":1.1933,"open":25.41,"prevYearClose":25.2418},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DBV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-03-06","symbol":"DBV","reason":null,"defaultRemindTime":1678113000000,"announcedDate":"2023-01-24","type":"delisting","dateTimestamp":1678078800000},{"market":"US","date":"2022-12-19","symbol":"DBV","amount":0.19276,"defaultRemindTime":1671460200000,"name":"Invesco DB G10 Currency Harvest Fund","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2019-12-23","symbol":"DBV","amount":0.3445,"name":"PowerShares DB G10 Currency Harv","recordDate":"2019-12-31","payableDate":"2019-12-24","currency":"USD","type":"dividend","dateTimestamp":1577077200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DBV\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-31","value":0.3445,"currency":"USD"},{"executeDate":"2022-12-19","recordDate":"2022-12-20","paymentDate":"2022-12-23","value":0.19276,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DBV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DBV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610976671","title":"DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610976671","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610976671?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:30","pubTimestamp":1770759000,"startTime":"0","endTime":"0","summary":"Chtillon, France, February 10, 2026 DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235812/0/en/DBV-Technologies-to-Present-Additional-Data-from-the-VITESSE-Phase-3-Study-of-the-VIASKIN-Peanut-Patch-in-Children-Ages-4-7-Years-and-Discuss-Future-of-EPIT-in-the-Treatment-Landsc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV"],"gpt_icon":0},{"id":"2610661875","title":"DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2610661875","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610661875?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:30","pubTimestamp":1770672600,"startTime":"0","endTime":"0","summary":"Attachment. PDF Version","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234927/0/en/DBV-Technologies-to-Participate-in-the-Guggenheim-Securities-Emerging-Outlook-Biotech-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","SMMF","BK4585","DBV","BK4211","BK4588"],"gpt_icon":0},{"id":"2604591232","title":"DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604591232","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604591232?lang=en_us&edition=fundamental","pubTime":"2026-01-17 07:11","pubTimestamp":1768605060,"startTime":"0","endTime":"0","summary":"Chtillon, France, January 16, 2026 DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing  The C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/16/3220592/0/en/DBV-Technologies-Announces-166-7-Million-in-Gross-Proceeds-Following-the-Full-Exercise-of-the-ABSA-Warrants-and-BS-Warrants-Issued-on-its-March-2025-Financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV","BK4156"],"gpt_icon":0},{"id":"2603760702","title":"Cantor Fitzgerald Reaffirms Their Buy Rating on DBV Technologies SA – American (DBVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603760702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603760702?lang=en_us&edition=fundamental","pubTime":"2026-01-15 20:56","pubTimestamp":1768481804,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on DBV Technologies SA – American yesterday and set a price target of $48.00. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-dbv-technologies-sa-american-dbvt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-dbv-technologies-sa-american-dbvt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBV","AFG"],"gpt_icon":0},{"id":"2601892393","title":"Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892393","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601892393?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:00","pubTimestamp":1767819600,"startTime":"0","endTime":"0","summary":"Attachment. PDF Version","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/07/3214879/0/en/Half-Year-Report-on-the-DBV-Technologies-Liquidity-Contract-with-ODDO-BHF.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4162","DBV","BHF"],"gpt_icon":0},{"id":"2592923919","title":"Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923919","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592923919?lang=en_us&edition=fundamental","pubTime":"2025-12-17 23:07","pubTimestamp":1765984020,"startTime":"0","endTime":"0","summary":"U.S. stocks were mixed, with the Dow Jones index gaining more than 150 points on Wednesday.Shares of Toro Co  rose sharply during Wednesday's session following better-than-expected quarterly earnings.Toro reported quarterly earnings of 91 cents per share which beat the analyst consensus estimate of 87 cents per share. The company reported quarterly sales of $1.066 billion which beat the analyst consensus estimate of $1.048 billion.Here are some other big stocks recording gains in today’s session.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/17/Toro-Company.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/17/Toro-Company.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/25/12/49450953/toro-dbv-technologies-udemy-abm-industries-and-other-big-stocks-moving-higher-on-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/12/49450953/toro-dbv-technologies-udemy-abm-industries-and-other-big-stocks-moving-higher-on-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1165135440.EUR","LU1543694498.USD","BK4152","TTC","UDMY","BK4204","DBV","BK4120","ABM"],"gpt_icon":0},{"id":"2592990483","title":"DBV Technologies Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990483","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592990483?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:04","pubTimestamp":1765976640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DBVT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 08:04 ET (13:04 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV"],"gpt_icon":0},{"id":"2592991845","title":"U.S. Stocks to Watch: Tesla, Netflix, Lennar, DBV Technologies, Micron, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2592991845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592991845?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:26","pubTimestamp":1765970782,"startTime":"0","endTime":"0","summary":"Stock futures rose Wednesday as investors tried to make sense of delayed U.S. jobs data.These stocks were poised to make moves Wednesday:$Tesla(TSLA)$ climbed 0.1% ahead of the opening bell. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2383074a52c258f664e165501a1e7f86","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0353189763.USD","SG9999015978.USD","IE00BK4W5L77.USD","LU1823568750.SGD","LU2048586759.USD","LU2087625088.SGD","LU1066051498.USD","LU2106854487.HKD","LU1861215975.USD","LU2264538146.SGD","LU1267930813.SGD","BK4560","LU0215105999.USD","LU1861559042.SGD","LU1323610961.USD","LU2063271972.USD","BK4555","LU2471134952.CNY","LU1974910355.USD","LU2023250843.SGD","LU2362540622.SGD","LU0345770308.USD","LU0689472784.USD","LU0210533765.USD","LU0980610538.SGD","BK4548","IE00BK4W5M84.HKD","LU1066053197.SGD","LU0234572021.USD","LU1989764664.SGD","LEN/WD","LU2290526834.HKD","LU0130517989.USD","GIS","TSYW.SI","LU0256863902.USD","IE00BKVL7J92.USD","LU0964807845.USD","LU1839511570.USD","LU0097036916.USD","LU0823414478.USD","IE00BQXX3F31.USD","LU2249611893.SGD","LU1720051017.SGD","LU0345769631.USD","LU0417517546.SGD","LU1232071149.USD","IE00BJLML261.HKD","LU0323591593.USD","LU2462157665.USD","IE00B1XK9C88.USD","IE00B19Z8W00.USD","LU2237957902.USD","LU1989763690.USD","LU0157215616.USD","LU1861220033.SGD","LU0889566641.SGD","LU2211815571.USD","BK4579","LU0106261372.USD","LU1201861249.SGD","LU1548497426.USD","BK4588","BK4532","LU2750360997.AUD","GB00BDT5M118.USD","LU1035775433.USD","IE0002270589.USD","LU1435385759.SGD","BK4596","LU2602419157.SGD","LU2023250330.USD","LU1720051108.HKD","LU1861558580.USD","IE00B19Z3B42.SGD","SGXZ23171101.USD","LU2360107168.USD","LU2403377893.USD","LU2361044949.HKD","BK4574","BK4512","LU0127658192.USD","LU0648001328.SGD","IE0034235303.USD","LU0943347566.SGD","BK4587","LU1917777945.USD","LU1366333091.USD","LU2552382215.SGD","SG9999015945.SGD","LU2087621335.USD","IE00BQXX3C00.GBP","LU0868494708.USD","LU2552382132.HKD","LU2023250504.SGD","WBD","LU2750360641.GBP","LU1914381329.SGD","LU2456880835.USD","LU1674673691.USD","BK4524","LU2471134523.USD","LU0203345920.USD","BK4088","LU0942090050.USD","BK4533","LU1629891620.HKD","BK4585","LU2357305700.SGD","BK4553","BK4194","BK4612","BK4575","LU2361044865.SGD","LU2860962120.EUR","LU0820561818.USD","BK4566","BK4598","LU1551013425.SGD","LU2931357623.SGD","LEN","LU0345770993.USD","LU2420271590.USD","NFLX","BK4099","LU1066051225.USD","LU2461242641.AUD","LU1366192091.USD","LU2471134879.HKD","BK4504","LU1585245621.USD","BK4125","LU0274383776.USD","LU0079474960.USD","IE00B7SZLL34.SGD","DBVT","BK4592","SG9999015986.USD","SG9999004303.SGD","DBV","BK4139","IE00B1BXHZ80.USD","LU0466842654.USD","LU0820561909.HKD","SGXZ81514606.USD","LU1429558221.USD","LU2552382058.USD","LU1988902786.USD","SGXZ51526630.SGD","BK4507","IE00B19Z3581.USD","LU1316542783.SGD","LU2108987350.USD","LU2756315318.SGD","BK4543","IE00BWXC8680.SGD","LU1267930730.SGD","LU0130102774.USD","LU0081259029.USD","LU2250418816.HKD","PARA","IE00B19Z8X17.USD","LU0053666078.USD","LU1551013342.USD","LU2543165471.USD","LU2756315664.SGD","LU2896262040.SGD","LU2361045086.USD","LU0225283273.USD","LU0708995401.HKD","LU1145028129.USD","IE00BSNM7G36.USD","BK4559","LU1674673428.USD","BK4581","LU0082616367.USD","FTNT","LU2236285917.USD","LU0203201768.USD","LU0719512351.SGD","LU0868494617.USD","LU0256863811.USD","LU2089985449.USD","IE00BQXX3D17.EUR","BK4516","LU0882574139.USD","PGRE","BK4527","LU0786609619.USD","IE00BKPKM429.USD","LU0149725797.USD","LU0345769128.USD","BK4550","IE00B19Z9505.USD","SG9999015952.SGD","LU1127390331.HKD","LU0820562030.AUD","BK4554","IE00BZ1G4Q59.USD","LU0353189680.USD","LU0203347892.USD","MU","LU0198837287.USD","LU1064131342.USD","BK4212","TSLA","LU0203202063.USD","BK4223","LU0792757196.USD","LU0109391861.USD","LU0234570918.USD","LU2471134796.USD","BK4097","LU0056508442.USD","LU1852331112.SGD","LU0077335932.USD","LU0170899867.USD","LU0348723411.USD","LU1066051811.HKD","LU1430594728.SGD","LU2360106780.USD","LU2362541513.USD","LU2326559502.SGD","BK4108","LU1778281490.HKD","BK4551","LU0672654240.SGD","BK4534","BK4141","LU0316494557.USD","LU1989763427.SGD","LU1069344957.HKD","LU0314104364.USD","LU2237957811.SGD","SGXZ99366536.SGD","LU1046421795.USD","BK4511","LU0477156953.USD","LU0642271901.SGD","BK4604","IE0008368304.USD","LU0320765059.SGD","LU0823411888.USD","LU1814569148.SGD","LU2213496289.HKD","LU2362541273.HKD","LU0210536198.USD","BK4605","LU2286300806.USD","LU2417539215.USD","LU0006306889.USD"],"gpt_icon":1},{"id":"2592095320","title":"Stocks to Watch: DBV Technologies, Children's Place, Worthington","url":"https://stock-news.laohu8.com/highlight/detail?id=2592095320","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592095320?lang=en_us&edition=fundamental","pubTime":"2025-12-17 07:10","pubTimestamp":1765926600,"startTime":"0","endTime":"0","summary":"DBV Technologies said its patch for treating peanut allergies in children met its primary endpoint in a Phase 3 trial. The stock soared 65% to $29.90 in after-hours trading Tuesday.Children's Place recorded lower revenue as its turnaround strategy dented e-commerce sales. The stock slid 32% to $5.01 after the bell.Worthington Enterprises recorded lower quarterly profit and said it will buy LSI Group for $205 million. Shares declined 7% to $52.40.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV","DBVT","PLCE","BK4191","BK4161","BK4094","WOR","BK4139","BK4006"],"gpt_icon":0},{"id":"2592025937","title":"DBV Technologies Peanut Allergy Patch Meets Primary Endpoint in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2592025937","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592025937?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:23","pubTimestamp":1765920180,"startTime":"0","endTime":"0","summary":"DBV Technologies patch treatment for children allergic to peanuts met its primary endpoint in a Phase 3 trial.The French biopharmaceutical company said Tuesday 46.6% of children who used the patch, named the Viaskin Peanut, met the treatment responder criteria after 12 months. That compared with 14.8% of children in the placebo group.Safety results were consistent with previous clinical programs, with the most common adverse effect being mild-to-moderate local skin reactions where the patch was applied.DBV enrolled 654 children aged 4 to 7 years in the trial.The company is moving forward with plans to submit a biologics license application for the patch in the U.S. in the first half of next year.The Food and Drug Administration previously granted breakthrough therapy designation for the patch, and DBV said it expects the license application could be granted priority review.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DBVT","DBV"],"gpt_icon":0},{"id":"2591625649","title":"Cantor Fitzgerald Initiates DBV Technologies With Overweight Rating, $42 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2591625649","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591625649?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:01","pubTimestamp":1765803664,"startTime":"0","endTime":"0","summary":"DBV Technologies SA (DBVT) has an average rating of overweight and mean price target of $26.96, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DBV"],"gpt_icon":0},{"id":"2591044643","title":"DBV Technologies Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2591044643","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591044643?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:55","pubTimestamp":1765799700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DBVT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 06:55 ET (11:55 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV"],"gpt_icon":0},{"id":"2591434436","title":"DBV Technologies Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2591434436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591434436?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:43","pubTimestamp":1765798980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DBVT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 06:43 ET (11:43 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV"],"gpt_icon":0},{"id":"2588028393","title":"DBV Technologies Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2588028393","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588028393?lang=en_us&edition=fundamental","pubTime":"2025-12-04 00:11","pubTimestamp":1764778260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DBVT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 03, 2025 11:11 ET (16:11 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DBVT","DBV"],"gpt_icon":0},{"id":"2585157824","title":"Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585157824?lang=en_us&edition=fundamental","pubTime":"2025-11-21 04:35","pubTimestamp":1763670930,"startTime":"0","endTime":"0","summary":"Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA – American and keeping the price target at $19.00. Sam Slut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-dbv-technologies-amid-promising-viaskin-peanut-trial-developments-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-dbv-technologies-amid-promising-viaskin-peanut-trial-developments-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBV"],"gpt_icon":0},{"id":"2582327711","title":"DBV Technologies announces last patient visit completed in VITESSE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2582327711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582327711?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:50","pubTimestamp":1762944611,"startTime":"0","endTime":"0","summary":"DBV Technologies (DBVT) announced that the last patient visit has been completed in the company’s Phase 3 VITESSE clinical trial of the Viaskin Pea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dbv-technologies-announces-last-patient-visit-completed-in-vitesse-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dbv-technologies-announces-last-patient-visit-completed-in-vitesse-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBVT","BK4139","DBV"],"gpt_icon":0},{"id":"2582346555","title":"DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2582346555","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582346555?lang=en_us&edition=fundamental","pubTime":"2025-11-12 12:50","pubTimestamp":1762923000,"startTime":"0","endTime":"0","summary":"Chtillon, France, November 11, 2025 DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years Company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3185885/0/en/DBV-Technologies-Announces-Last-Patient-Visit-Completed-in-VITESSE-Phase-3-Clinical-Trial-of-VIASKIN-Peanut-Patch-in-Peanut-Allergic-Children-Aged-4-7-Years.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV"],"gpt_icon":0},{"id":"2579666489","title":"Kepler Capital  Reaffirms Their Buy Rating on DBV Technologies (0QAJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579666489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579666489?lang=en_us&edition=fundamental","pubTime":"2025-10-31 09:48","pubTimestamp":1761875293,"startTime":"0","endTime":"0","summary":"In a report released on October 29, Justine Telliez from Kepler Capital maintained a Buy rating on DBV Technologies, with a price target of €6.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-dbv-technologies-0qaj-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-dbv-technologies-0qaj-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBV"],"gpt_icon":0},{"id":"2579170390","title":"DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2579170390","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579170390?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:30","pubTimestamp":1761856200,"startTime":"0","endTime":"0","summary":"Chtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177970/0/en/DBV-Technologies-Announces-Appointment-of-Philina-Lee-Ph-D-to-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBV"],"gpt_icon":0},{"id":"2579976191","title":"DBV Technologies to Sell $30 Million of ADSs Under ATM Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2579976191","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579976191?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:01","pubTimestamp":1761814894,"startTime":"0","endTime":"0","summary":"DBV Technologies (DBVT) said late Wednesday it agreed to sell $30 million worth of American depositary shares under its at-the-market program.With the offering, the company said it now expects its cash runway to extend to the end of Q4 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","DBVT","DBV"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}